DIABINESE TAB 100MG DIN 00024708
Health Canada record
| Active ingredient(s) | CHLORPROPAMIDE 100 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | A10BB02 CHLORPROPAMIDE |
| Original market date | 31-Dec-1958 |
| Current status date | 18-Oct-2000 |
| Source | Health Canada DPD |
Establishment licence of the holder
Pfizer Canada ULC — licence 100255, currently licensed, last inspection rating C (2023-08-07).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CHLORPROPAMIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00399302 | APO CHLORPROPAMIDE TAB 100MG | APOTEX INC | Tablet | CHLORPROPAMIDE 100 MG | Cancelled Post Market |
| 00312711 | APO CHLORPROPAMIDE TAB 250MG | APOTEX INC | Tablet | CHLORPROPAMIDE 250 MG | Cancelled Post Market |
| 00586773 | CHLORPROPAMIDE 100 TAB USP | PRO DOC LIMITEE | Tablet | CHLORPROPAMIDE 100 MG | Cancelled Post Market |
| 00156728 | CHLORPROPAMIDE TAB 250MG | PRO DOC LIMITEE | Tablet | CHLORPROPAMIDE 250 MG | Cancelled Post Market |
| 00430986 | CHLORPROPAMIDE TAB 250MG | DUCHESNAY INC | Tablet | CHLORPROPAMIDE 250 MG | Cancelled Post Market |
| 00024716 | DIABINESE TAB 250MG | PFIZER CANADA ULC | Tablet | CHLORPROPAMIDE 250 MG | Cancelled Post Market |
| 00021350 | NOVO-PROPAMIDE 250MG | NOVOPHARM LIMITED | Tablet | CHLORPROPAMIDE 250 MG | Cancelled Post Market |
International API supply for CHLORPROPAMIDE
0 valid EDQM Certificates of Suitability from 0 holders. 1 active FDA Drug Master Files.
Request a quote for DIABINESE TAB 100MG